Immunophenotypical minimal residual disease as a short term endpoint for monitoring effects of targeted inhibitors in acute myeloid leukemia.

CJ Hess, N Feller, F Denkers, PA Merle, GJ Ossenkoppele, Q Waisfisz, GJ Schuurhuis

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)162A-162A
Issue number11
Publication statusPublished - 16 Nov 2005

Cite this